Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD9291 in EGFRm NSCLC with Brain Metastases
NCT02736513Phase 2Unknown
- Sponsor
- Soroka University Medical Center
- Start
- May 2016
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of osimertinib in non-small cell lung cancer (NSCLC), sponsored by Soroka University Medical Center. Status: unknown.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02736513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02736513.